HKG:3933 Revenue

The United Laboratories International Holdings had revenue of 7.52B CNY in the half year ending June 30, 2025, with 8.86% growth. This brings the company's revenue in the last twelve months to 14.10B, up 0.66% year-over-year. In the year 2024, The United Laboratories International Holdings had annual revenue of 13.76B with 0.14% growth.

Revenue (ttm)

14.10B CNY

Revenue Growth

+0.66%

P/S Ratio

1.66

Revenue / Employee

810.45K CNY

Employees

17,400

Market Cap

25.67B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	13.76B	19.06M	0.14%
Dec 31, 2023	13.74B	2.41B	21.22%
Dec 31, 2022	11.33B	1.63B	16.81%
Dec 31, 2021	9.70B	930.95M	10.61%
Dec 31, 2020	8.77B	379.89M	4.53%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Xuanzhu Biopharmaceutical	35.02M
Grand Pharmaceutical Group	11.70B
Sunshine Lake Pharma	3.96B
China Resources Pharmaceutical Group	285.94B
OneRobotics (Shenzhen)	801.23M
Simcere Pharmaceutical Group	7.79B
China Medical System Holdings	8.61B
Ab&B Bio-Tech CO., LTD. JS	354.77M

Revenue Rankings

The United Laboratories International Holdings News

13 days ago - Novo Nordisk, United Laboratories International Announce Positive Topline Data From UBT251 Trial - Nasdaq
13 days ago - Novo Nordisk And United Lab Reports Positive Results From Chinese Phase 2 Trial Of UBT251 In Obesity - Nasdaq

More News